Preparation method and application of gastric volume-occupying hydrogel particles for obesity intervention

Through polysaccharide polymer compounding and high-pressure homogenization technology, gastric content hydrogel particles with high strength and good swelling performance were prepared, which solved the contradiction between swelling performance and mechanical stability of hydrogels in obesity intervention. Effective gastric retention and sustained satiety effects were achieved.

CN116807980BActive Publication Date: 2024-11-05ACORN MEIJIAN IND INVESTMENT CO LTD
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202310837872.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-07-10
Publication Date
2024-11-05
Estimated Expiration
2043-07-10

AI Technical Summary

Technical Problem

There is a contradiction between the swelling performance and mechanical stability of existing high-strength hydrogels, and it is difficult to have both high swelling performance and long-term gastric retention effect, affecting the effect of obesity intervention.

Method used

The gastric content hydrogel particles are prepared by compounding between different polysaccharide polymers. By high-pressure homogenization and controlling the speed and pressure of the crosslinking agent solution, porous hydrogel particles with high hydrophilicity and high strength are prepared. , prolong the emptying time of the hydrogel in the stomach.

Benefits of technology

The balance between high water absorption swelling performance and high gel strength is achieved, effectively extending the duration of satiety, and is suitable for obesity intervention.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004329510040000041
    Figure BDA0004329510040000041
  • Figure BDA0004329510040000051
    Figure BDA0004329510040000051
  • Figure BDA0004329510040000052
    Figure BDA0004329510040000052
Patent Text Reader

Abstract

The present invention discloses a preparation method and application of gastric volume hydrogel particles for obesity intervention, belonging to the field of hydrogel technology, the preparation method comprises (1) dissolving a water-soluble polysaccharide polymer to obtain a polysaccharide aqueous solution; (2) adding a crosslinker solution to the polysaccharide aqueous solution, and high-pressure homogenization to obtain a composite solution, wherein the addition rate of the crosslinker solution is 1-3 ml / min, and the pressure of the high-pressure homogenization is 10000-13000 psi; (3) drying the composite solution and crushing it to obtain the gastric volume hydrogel particles. The present invention prepares super hydrophilic porous hydrogel particles by controlling the addition rate of the crosslinker solution and the pressure of the high-pressure homogenization. Experiments have shown that the gastric volume hydrogel particles of the present invention have high water absorption and swelling properties and high gel strength, which can prolong the emptying time of the hydrogel in the stomach and effectively prolong the duration of satiety.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of hydrogels, and relates to a preparation method and application of gastric volume-occupying hydrogel particles for obesity intervention. Background Art

[0002] With the development of society and the improvement of living standards, obesity has become a serious problem that affects people's health and quality of life in today's society. Complications of morbid obesity include sleep apnea, non-insulin-dependent diabetes mellitus, hypertension, coronary artery atherosclerosis, gallstones, dyslipidemia, degenerative joint disease, etc. Obesity intervention treatment can reduce the incidence and mortality of obesity-related diseases. At present, the main methods of obesity intervention include improving lifestyle habits, drug therapy and surgical treatment. However, the effect of simply improving lifestyle habits on morbid obesity is limited. Although drug therapy has certain therapeutic effects, it is often accompanied by certain side effects, such as vomiting, diarrhea and endocrine disorders. Surgical treatment can effectively reduce weight, but it is traumatic and has a long recovery period, so it is not the first choice for obesity treatment. Therefore, there is an urgent need to develop low-side-effect, non-traumatic obesity treatments.

[0003] CN114432338A discloses a polymer hydrogel with high acid and alkali resistance, which is cross-linked by polysaccharides and multivalent metal ions, and the weight ratio of multivalent metal ions to polysaccharides is 0.01-1%. The swelling rate of the hydrogel under pH 1.5-3 is not less than 100g / g, and the swelling rate under pH 6-8 is not less than 90g / g. The invention semi-stretches the spatial structure of polysaccharides under the action of polyols to complete intramolecular cross-linking, and then adds iron ions to achieve intermolecular cross-linking between polysaccharides and iron ions, taking both internal and external factors into consideration. The prepared hydrogel has a high swelling rate in both gastric juice and intestinal juice, thereby prolonging the duration of satiety.

[0004] CN113854567A discloses an edible hydrogel, which is a cross-linked product of a polysaccharide or a polysaccharide derivative and a dibasic acid, has a three-dimensional network structure with siphon and capillary functions, has extremely strong water absorption and water locking capabilities in the gastrointestinal tract, has a high storage modulus, and provides a rapid and sustained feeling of fullness.

[0005] Hydrogel has good biocompatibility and hydrophilicity. Due to its high water content, drying and dehydration can rapidly reduce the volume of the hydrogel carrier. After absorbing water again, the hydrogel carrier can expand rapidly, achieving gastric retention of the hydrogel. While reducing the amount of food intake, it can also slow down the emptying of food in the stomach and reduce the desire to eat, thereby achieving the purpose of controlling weight.

[0006] In order to prolong the gastric retention time, researchers have tried to develop high-strength hydrogels, but high-strength hydrogels face a contradiction between swelling properties and mechanical stability. This is mainly because the mechanical properties of the hydrogel are positively correlated with the molecular chain density. Swelling due to water absorption will cause the hydrogel molecular chain density to decrease, resulting in poor mechanical stability of the gel. On the contrary, if the long-term mechanical stability of the hydrogel is to be maintained, the high swelling properties of the hydrogel need to be sacrificed, which increases the risk of the hydrogel being excreted by the stomach, which is not conducive to gastric retention applications. Therefore, the development of a long-term gastric retention hydrogel with both high swelling properties and mechanical stability for obesity intervention has important clinical significance. Summary of the invention

[0007] In order to solve the above technical problems, the present invention provides a method for preparing and using gastric volume-occupying hydrogel particles for obesity intervention. The gastric volume-occupying hydrogel particles prepared by the present invention by compounding different polysaccharide polymers have good hydrophilicity and high swelling performance. At the same time, they have high strength and can prolong the emptying time of the hydrogel in the stomach, effectively prolonging the duration of fullness.

[0008] In order to achieve the above object, the present invention adopts the following technical solutions:

[0009] A method for preparing gastric volume-occupying hydrogel particles for obesity intervention comprises the following steps:

[0010] (1) dissolving a water-soluble polysaccharide polymer to obtain a polysaccharide aqueous solution;

[0011] (2) adding a crosslinker solution to the polysaccharide aqueous solution obtained in step (1), and homogenizing under high pressure to obtain a composite solution;

[0012] (3) Drying and crushing the composite solution obtained in step (3) to obtain the gastric volume-occupying hydrogel particles.

[0013] Preferably, the water-soluble polysaccharide polymer in step (1) includes at least one of polysaccharide gum, cellulose derivatives, chondroitin sulfate, dextran, hyaluronic acid, chitin, chitosan, polydextrose, β-cyclodextrin and sodium alginate.

[0014] The polysaccharide gum comprises at least one of konjac gum, carrageenan, guar gum, locust bean gum, xanthan gum, gelatin, gellan gum, dawa gum, pectin, welan gum, sambucus gum and gum arabic;

[0015] The cellulose derivative includes at least one of sodium carboxymethylcellulose, carboxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, methylcellulose, ethylcellulose, carboxymethylhydroxyethylcellulose, carboxymethylhydroxypropylcellulose and carboxymethylethylcellulose.

[0016] Further preferably, the water-soluble polysaccharide polymer is at least one of gum dawa, pectin and sodium carboxymethyl cellulose; further preferably, the water-soluble polysaccharide polymer is gum dawa, pectin and sodium carboxymethyl cellulose; further preferably, the mass ratio of gum dawa, pectin and sodium carboxymethyl cellulose is 6-10:1:0.8-2; most preferably, it is 8:1:1.

[0017] More preferably, the mass concentration of the polysaccharide aqueous solution in step (1) is 0.5%-2%.

[0018] Preferably, the cross-linking agent in step (2) is at least one of citric acid, malic acid, succinic acid, tartaric acid, suberic acid, calcium phosphate, calcium carbonate, calcium sulfate, calcium oxide, calcium citrate, calcium lactate, calcium chloride, calcium ascorbate, calcium tartrate, calcium acetate, calcium gluconate and calcium malate; further preferably, the cross-linking agent is tartaric acid and malic acid; further preferably, the cross-linking agent is tartaric acid and malic acid in a mass ratio of 1:3-5.

[0019] Further preferably, the mass concentration of the cross-linking agent solution in step (2) is 15%-20%.

[0020] Further preferably, in step (2), the volume ratio of the cross-linking agent solution to the polysaccharide solution is 1:15-30.

[0021] Preferably, in step (2), the cross-linking agent solution is added at a rate of 1-3 ml / min, the high pressure homogenization pressure is 10000-15000 psi, and the time is 80-120 s.

[0022] Preferably, the drying in step (3) is: drying at 50-80°C for 6-8h, and then drying at 80-150°C for 10-60min.

[0023] The present invention also provides the use of the gastric volume-occupying hydrogel particles prepared by the above preparation method in the preparation of food and / or medicine for obesity intervention.

[0024] The present invention also provides a product for obesity intervention, which is made from the gastric volume-occupying hydrogel particles prepared by the above preparation method.

[0025] The beneficial effects of the present invention are:

[0026] (1) The present invention prepares super-hydrophilic porous hydrogel particles by controlling the addition speed of the crosslinking agent solution and the pressure of the high-pressure homogenization. Experiments have shown that the gastric volume-occupying hydrogel particles prepared by the present invention have high water absorption and swelling properties and high gel strength, which can prolong the emptying time of the hydrogel in the stomach and effectively prolong the duration of satiety.

[0027] (2) The preparation method of the present invention is simple, the process is controllable, the product quality is stable, and it is suitable for large-scale production. DETAILED DESCRIPTION

[0028] The following describes the embodiments of the present invention through specific examples, and those skilled in the art can easily understand other advantages and effects of the present invention from the contents disclosed in this specification. The present invention can also be implemented or applied through other different specific embodiments, and the details in this specification can also be modified or changed in various ways based on different viewpoints and applications without departing from the spirit of the present invention.

[0029] Before further describing the specific embodiments of the present invention, it should be understood that the scope of protection of the present invention is not limited to the specific embodiments described below; it should also be understood that the terms used in the examples of the present invention are for describing specific embodiments rather than for limiting the scope of protection of the present invention.

[0030] When the embodiment gives a numerical range, it should be understood that, unless otherwise specified in the present invention, the two endpoints of each numerical range and any numerical value between the two endpoints can be selected. Unless otherwise defined, all technical and scientific terms used herein have the same meanings as those of ordinary skill in the art to which the present invention belongs.

[0031] The present invention does not limit the sources of the raw materials used. Unless otherwise specified, the raw materials used in the present invention are common commercial products in the technical field.

[0032] Example 1

[0033] A method for preparing gastric volume-occupying hydrogel particles for obesity intervention comprises the following steps:

[0034] (1) dissolving a water-soluble polysaccharide polymer in water to obtain a polysaccharide solution with a mass concentration of 0.5%;

[0035] (2) adding a cross-linking agent aqueous solution with a mass concentration of 15% to the polysaccharide aqueous solution obtained in step (1) at a volume ratio of 15:1, the cross-linking agent solution is added at a rate of 1 ml / min, and high pressure homogenization is performed with a controlled pressure of 10,000 psi for 120 seconds to obtain a composite solution; wherein the cross-linking agent is calcium chloride.

[0036] (3) The composite solution obtained in step (3) is pre-dried at 50° C. for 8 h, passed through an 80-mesh sieve, and the material on the sieve is dried at 80° C. for 60 min and crushed to obtain the gastric volume-occupying hydrogel particles.

[0037] The specific process parameters of Example 1 are shown in Table 1.

[0038] Table 1 Specific process parameters of Example 1

[0039]

[0040] Example 2

[0041] A method for preparing gastric volume-occupying hydrogel particles for obesity intervention. The difference between this embodiment and embodiment 1 is that the specific process parameters are different, as shown in Table 2.

[0042] Table 2 Specific process parameters of Example 2

[0043]

[0044] Example 3

[0045] A method for preparing gastric volume-occupying hydrogel particles for obesity intervention. The difference between this embodiment and embodiment 1 is that the specific process parameters are different, as shown in Table 3.

[0046] Table 3 Specific process parameters of Example 3

[0047]

[0048] Example 4

[0049] A method for preparing gastric volume-occupying hydrogel particles for obesity intervention. The difference between this embodiment and embodiment 1 is that the specific process parameters are different, as shown in Table 4.

[0050] Table 4 Specific process parameters of Example 4

[0051]

[0052] Example 5

[0053] A method for preparing gastric volume-occupying hydrogel particles for obesity intervention. The difference between this embodiment and embodiment 1 is that the specific process parameters are different, as shown in Table 5.

[0054] Table 5 Specific process parameters of Example 5

[0055]

[0056] Example 6

[0057] A method for preparing gastric volume-occupying hydrogel particles for obesity intervention. The difference between this embodiment and embodiment 1 is that the specific process parameters are different, as shown in Table 6.

[0058] Table 6 Specific process parameters of Example 6

[0059]

[0060] Example 7

[0061] A method for preparing gastric volume-occupying hydrogel particles for obesity intervention. The difference between this embodiment and embodiment 1 is that the specific process parameters are different, as shown in Table 7.

[0062] Table 7 Specific process parameters of Example 7

[0063]

[0064] Example 8

[0065] A method for preparing gastric volume-occupying hydrogel particles for obesity intervention. The difference between this embodiment and embodiment 1 is that the specific process parameters are different, as shown in Table 8.

[0066] Table 8 Specific process parameters of Example 8

[0067]

[0068] Comparative Example 1

[0069] A method for preparing gastric volume-occupying hydrogel particles for obesity intervention, the difference between this embodiment and embodiment 1 is that:

[0070] The rate of the crosslinker solution was 5 ml / min.

[0071] Comparative Example 2

[0072] A method for preparing gastric volume-occupying hydrogel particles for obesity intervention, the difference between this embodiment and embodiment 1 is that:

[0073] Mechanical stirring was used with a rotation speed of 200 rpm and a time of 20 min.

[0074] Comparative Example 3

[0075] A method for preparing gastric volume-occupying hydrogel particles for obesity intervention, the difference between this embodiment and embodiment 1 is that:

[0076] The addition rate of the cross-linking agent solution was 0.5 ml / min, the pressure of the high-pressure homogenization was 13000 psi, and the time was 90 s.

[0077] Comparative Example 4

[0078] A method for preparing gastric volume-occupying hydrogel particles for obesity intervention, the difference between this embodiment and embodiment 8 is that:

[0079] The mass ratio of gum dawa, pectin and sodium carboxymethyl cellulose in the water-soluble polysaccharide polymer is 1:1:1.

[0080] 1. Gastric volume hydrogel particle swelling test

[0081] (1) Preparation of artificial gastric juice: Take 16.4 ml of dilute hydrochloric acid, add 800 ml of water and 10 g of pepsin, shake well, and dilute with water to 1000 ml. The final pH value is about 2.0.

[0082] (2) Gastric capacity-occupying hydrogel particles: Gastric capacity-occupying hydrogel particles prepared in Examples 1-8 and Comparative Examples 1-4 had a diameter of 1 mm.

[0083] (3) Test method: Weigh 1 g of hydrogel particles (occupying gastric volume) and record it as m0. Add it into 200 ml of artificial gastric juice and place it at 37°C for 30 min. Pass it through a 5-mesh sieve, filter it, let it stand for 60 min, weigh it and record it as m. Calculate the swelling degree according to the formula Q = (m-m0) × 100% / m0. Repeat 3 times for each group and take the average value.

[0084] The results are shown in Table 9.

[0085] Table 9 Stomach volume hydrogel particle swelling data

[0086] Group m0 / g m / g Swelling degree % Example 1 1.02 32.97 3132.4 Example 2 1.04 30.89 2870.2 Example 3 1.00 31.90 3090.0 Example 4 1.00 30.85 2985.0 Example 5 0.98 33.95 3364.3 Example 6 1.00 78.35 7735.0 Example 7 1.03 80.43 7713.6 Example 8 1.01 84.97 8312.9 Comparative Example 1 0.99 9.42 851.5 Comparative Example 2 1.00 9.31 831.0 Comparative Example 3 1.01 10.49 929.0 Comparative Example 4 1.00 62.29 6087.1

[0087] As can be seen from Table 9 above, the stomach-occupying hydrogel particles of the present invention are placed in artificial gastric juice at 37°C for 60 minutes, and the swelling degree is 2870.2-8312.9%, indicating that the stomach-occupying hydrogel particles provided by the present invention have high water absorption and swelling properties, can effectively occupy the stomach volume, and increase the feeling of fullness.

[0088] At the same time, the swelling degree of comparative example 1 is only 851.5%, which may be due to the excessive flow rate of the crosslinking agent solution, the gel formation speed is too fast, the gel network structure becomes dense, and the swelling performance is reduced; it can be seen from comparative example 2 that compared with conventional mechanical stirring, the high-pressure homogenization of the present invention can significantly increase the swelling degree of the hydrogel particles occupying the stomach, which may be caused by the high-pressure homogenization treatment of appropriate pressure, which changes the aggregation degree of the gel during the gelation process. It can be seen from comparative example 3 that when the flow rate of the crosslinking agent solution is too slow, under the condition of high-pressure homogenization, the degree of gel aggregation is too large, resulting in a decrease in swelling degree, which is only 929.0%.

[0089] 2. Mechanical properties test of hydrogel particles occupying gastric volume

[0090] The gastric volume hydrogels prepared in Examples 1-8 and Comparative Examples 1-4 were made into cylindrical shapes with a height of 1 cm and a diameter of 2 cm, respectively, and were immersed in artificial gastric juice at 37°C for 120 min, filtered for 10 min, and the surface liquid was wiped off. The gel hardness was measured using a texture analyzer, with a probe model of P 0.5 and a probe trigger force of 1.0 g. The specific operation was as follows: the test rate before compression was 15 mm / min, the test rate during compression was 60 mm / min, and the test rate after compression was 60 mm / min. The magnitude of the force corresponding to the gel rupture point was defined as the gel strength. Three samples were repeated in parallel, and the results were averaged. The results are shown in Table 10.

[0091] Table 10 Data on gel compression strength

[0092] Group Gel strength / g Example 1 868.3 Example 2 1031 Example 3 908 Example 4 985 Example 5 808.7 Example 6 1037.3 Example 7 1014.5 Example 8 1001.8 Comparative Example 1 1704.7 Comparative Example 2 1841.3 Comparative Example 3 1665 Comparative Example 4 504

[0093] As can be seen from Table 10 above, after 120 minutes of swelling, the gel strength of the gastric hydrogel particles prepared by the present invention still reaches 808.7-1037.3 g, which is relatively high in strength. The solid form can be well maintained in the stomach, effectively preventing the gel from being discharged, prolonging the emptying time of the hydrogel in the stomach, and effectively prolonging the duration of fullness.

[0094] Combining Tables 9 and 10, it can be seen that the gastric volume-occupying hydrogel particles of the present invention have high water absorption and swelling properties, can effectively occupy the volume of the stomach, and increase the feeling of fullness. At the same time, the gel has high strength and can better maintain a solid form in the stomach, effectively preventing the gel from being discharged, prolonging the emptying time of the hydrogel in the stomach, and effectively prolonging the duration of fullness.

[0095] Although the gastric volume-occupying hydrogel particles prepared in Comparative Examples 1-3 have high gel strength, their water absorption and swelling properties are poor, and the satiety experience is poor. The gastric volume-occupying hydrogel particles prepared in Comparative Example 4 have good water absorption and swelling properties, but their gel strength is low, and the gastric emptying time is short, which cannot meet the demand for sustained satiety.

[0096] In summary, the present invention effectively balances the contradiction between high swelling property and high gel strength by controlling the addition speed of the cross-linking agent solution and the pressure of the high-pressure homogenization. The prepared gastric volume-occupying hydrogel particles have good hydrophilicity and high swelling performance. At the same time, they have high strength, which can prolong the emptying time of the hydrogel in the stomach and effectively prolong the duration of fullness.

[0097] The above is a further description of the present invention in conjunction with specific embodiments, but these embodiments are merely exemplary and do not constitute any limitation on the scope of the present invention. It should be understood by those skilled in the art that the details and forms of the technical solution of the present invention may be modified or replaced without departing from the spirit and scope of the present invention, but these modifications and replacements all fall within the scope of protection of the present invention.

Claims

1. A method for preparing gastric volume-occupying hydrogel particles for obesity intervention, characterized in that: The following steps are involved: (1) dissolving a water-soluble polysaccharide polymer to obtain a polysaccharide aqueous solution; (2) adding a crosslinker solution to the polysaccharide aqueous solution obtained in step (1), and homogenizing under high pressure to obtain a composite solution, wherein the crosslinker solution is added at a rate of 1-3 ml / min, the pressure of the high pressure homogenization is 10000-13000 psi, and the time is 80-120 s; (3) drying and crushing the composite solution obtained in step (2) to obtain the gastric volume-occupying hydrogel particles; The water-soluble polysaccharide polymer in step (1) is gum dawa, pectin and sodium carboxymethyl cellulose in a mass ratio of (6-10):1:(0.8-2); The mass concentration of the polysaccharide aqueous solution in step (1) is 0.5%-2%; The mass concentration of the cross-linking agent solution in step (2) is 15%-20%; the volume ratio of the cross-linking agent solution to the polysaccharide solution is 1:(20-30); The drying in step (3) is: drying at 50-80°C for 6-8h, and then drying at 80-150°C for 10-60min; The cross-linking agent is tartaric acid and malic acid in a mass ratio of 1:(3-5).

2. Use of the gastric volume-occupying hydrogel particles prepared by the preparation method according to claim 1 in the preparation of food and / or medicine for obesity intervention.

3. A product for obesity intervention, characterized in that: The gastric volume-occupying hydrogel particles are prepared by the preparation method according to claim 1.

Citation Information

Cited By

  • Composition with weight losing effect and application thereof

    CN122351422A